Octave Intelligence (OCTV -3.25%), an operational analysis software provider, reported its second-quarter results shortly before market open on Wednesday. A slight revenue miss on analyst estimates, coupled with a modest bottom-line beat, led to a mild investor sell-off. The stock closed the day down by a bit over 3%.
Second-quarter slides
Octave's revenue for the period was $398 million, representing a 4% year-over-year decline. On a brighter note, the company's recurring revenue, widely considered higher quality than the one-off variety, increased by 6% to $283 million. Zooming out, annualized recurring revenue (ARR) stood at $1.14 billion, up from the year-ago tally of almost $1.07 billion.
Image source: Getty Images.
As for profitability, net income not under generally accepted accounting principles (non-GAAP, or adjusted) fell to $95 million from the second quarter of 2025's $98 million.
Octave is still a new arrival to the stock market, following its May separation from Sweden-based industrial and technology company Hexagon.
It's just too bad that Octave didn't begin its new life with a top-line beat; analysts tracking the stock were, on average, expecting revenue of just over $400 million. At least the company edged past the consensus estimate of $0.32 per share.
In its earnings report, Octave quoted CEO Mattias Stenberg as saying that "We are moving faster and investing with focus, delivering strong free cash flow in the quarter while executing on our go-to-market priorities and deepening the platform and agentic capabilities that make our customers' operating context more valuable to them."

NASDAQ: OCTV
Key Data Points
In-line revenue guidance
Octave also proffered guidance. For the full year, it's anticipating ARR of nearly $1.19 billion to just under $1.21 billion. Total revenue is anticipated to be almost $1.64 billion to a bit below $1.67 billion; the consensus analyst estimate is $1.65 billion.
While Octave's profit margins are impressive, those declines on the top and bottom lines are concerning. Personally, I'd be a wait-and-see on this stock until the company proves it can growth -- the more consistent, the better.





